| [1] |
中国狼疮肾炎诊断和治疗指南编写组. 中国狼疮肾炎诊断和治疗指南[J]. 中华医学杂志,2019,99(44):3441-3455.
|
| [2] |
Roveta A, Parodi EL, Brezzi B,et al. Lupus nephritis from pathogenesis to new therapies: an update[J]. Int J Mol Sci,2024,25(16): 8981.
|
| [3] |
Borchers AT, Leibushor N, Naguwa SM, et al. Lupus nephritis: a critical review[J]. Autoimmun Rev,2012,12(2): 174-194.
|
| [4] |
Mussbacher M, Derler M, Basílio J, et al. NF-κB in monocytes and macrophages -an inflammatory master regulator in multitalented immune cells[J].Front Immunol, 2023, 14: 1134661.
|
| [5] |
Anilkumar S, Wright-Jin E. NF-κB as an inducible regulator of inflammation in the central nervous system[J]. Cells, 2024, 13(6): 485.
|
| [6] |
Zheng L, Sinniah R, Hsu SI. Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis[J]. J Histochem Cytochem, 2008,56(5): 517-529.
|
| [7] |
Boi R, Ebefors K, Nyström J. The role of the mesangium in glomerular function[J]. Acta Physiol (Oxf), 2023, 239(2): e14045.
|
| [8] |
Nowling TK. Mesangial cells in lupus nephritis[J].Curr Rheumatol Rep,2022, 23(12): 83.
|
| [9] |
Liu M, Zhang L, Wang Y, et al. Mesangial cell: a hub in lupus nephritis[J]. Front Immunol, 2022, 13: 1063497.
|
| [10] |
Jamaly S, Rakaee M, Abdi R, et al. Interplay of immune and kidney resident cells in the formation of tertiary lymphoid struc⁃tures in lupus nephritis[J]. Autoimmun Rev, 2021, 20(12): 102980.
|
| [11] |
Wang J, Wu Y, Mao M, et al. Sivelestat sodium alleviates ischemia-reperfusion-induced acute kidney injury via suppressing TLR4/Myd88/NF-κB signaling pathway in mice[J]. Drug Des Devel Ther, 2024, 18: 4449-4458.
|
| [12] |
Paust HJ, Song N, De Feo D, et al. CD4+ T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12[J]. Sci Transl Med, 2023, 15(687): eadd6137.
|
| [13] |
Zhang H, Sun SC. NF-κB in inflammation and renal diseases[J]. Cell Biosci, 2015, 5: 63.
|
| [14] |
Staal J, Beyaert R. Inflammation and NF-κB signaling in prostate cancer: mechanisms and clinical implications[J]. Cells, 2018, 7(9): 122.
|
| [15] |
Wang Y, Gao W. Effects of TNF-α on autophagy of rheumatoid arthritis fibroblast-like synoviocytes and regulation of the NF-κB signaling pathway[J]. Immunobiology, 2021, 226(2): 152059.
|
| [16] |
熊传银. 系膜增生性肾小球肾炎TNF-α、IL-6水平的变化及意义[J]. 热带医学杂志, 2007,7(6): 569-571.
|
| [17] |
胡瑞洁, 卢宏柱. 系膜细胞在肾脏损伤中的作用[J]. 中华实用儿科临床杂志, 2015,30(5): 392-394.
|
| [18] |
王珊珊, 张雪琴, 陆晨. 细胞间黏附分子-1在IgA肾病中的研究进展[J]. 临床肾脏病杂志, 2022,22(9): 775-779.
|
| [19] |
Kwok SK, Tsokos GC. New insights into the role of renal resident cells in the pathogenesis of lupus nephritis[J]. Korean J Intern Med, 2018, 33(2): 284-289.
|
| [20] |
Bhargava R, Li H, Tsokos GC. Pathogenesis of lupus nephritis: the contribution of immune and kidney resident cells[J]. Curr Opin Rheumatol, 2023, 35(2): 107-116.
|
| [21] |
Zou L, Sun L, Hua R, et al. Degradation of ubiquitin-editing enzyme A20 following autophagy activation promotes RNF168 nuclear translocation and NF-κB activation in lupus nephritis[J]. J Innate Immun, 2023, 15(1): 428-441.
|
| [22] |
Zheng L, Sinniah R, I-Hong Hsu S. In situ glomerular expression of activated NF-κB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy[J]. Virchows Arch, 2006, 448(2): 172-183.
|
| [23] |
Wang L, Zhang L, Hou Q, et al. Triptolide attenuates proteinuria and podocyte apoptosis via inhibition of NF-κB/GADD45B[J]. Sci Rep, 2018, 8(1): 10843.
|
| [24] |
Liu R, Wen X, Peng X, et al. Immune podocytes in the immune microenvironment of lupus nephritis (Review)[J]. Mol Med Rep, 2023, 28(5): 204.
|
| [25] |
Zhang H, Mao X, Sun Y, et al. NF-κB upregulates ubiquitin C-terminal hydrolase 1 in diseased podocytes in glomerulonephritis[J]. Mol Med Rep, 2015, 12(2): 2893-2901.
|
| [26] |
Hu Y, Qi C, Shi J, et al. Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress[J]. Cell Mol Life Sci, 2023, 80(4): 106.
|
| [27] |
Zhang H, Sun Y, Hu R, et al. The regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes[J]. Cell Signal, 2013, 25(7): 1574-1585.
|
| [28] |
Hong S, Healy H, Kassianos AJ. The emerging role of renal tubular epithelial cells in the immunological pathophysiology of lupus nephritis[J]. Front Immunol, 2020, 11: 578952.
|
| [29] |
Zhou P, Wan X, Zou Y, et al. Transforming growth factor beta (TGF-β) is activated by the CtBP2-p300-AP1 transcriptional complex in chronic renal failure[J]. Int J Biol Sci, 2020, 16(2): 204-215.
|
| [30] |
Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation[J]. Signal Transduct Target Ther, 2017, 2: 17023.
|
| [31] |
Wang M, Xu H, Chong Lee Shin OL, et al. Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways[J]. J Transl Med, 2019, 17(1): 122.
|
| [32] |
Ramanujam M, Steffgen J, Visvanathan S, et al. Phoenix from the flames: rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis[J]. Autoimmun Rev, 2020, 19(11): 102668.
|
| [33] |
免疫性肾小球疾病生物制剂治疗专家组. 免疫性肾小球疾病生物制剂治疗中国专家共识[J]. 中华肾脏病杂志, 2022,38(9):850-864.
|
| [34] |
Wan X, Yang J, Xing L, et al. Inhibition of IκB kinase β attenuates hypoxia-induced inflammatory mediators in rat renal tubular cells[J]. Transplant Proc, 2011, 43(5): 1503-1510.
|
| [35] |
Zhao J, Zhang H, Huang Y, et al. Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation[J]. Int Immunopharmacol, 2013, 17(1): 116-122.
|
| [36] |
Li D, Li B, Rui Y, et al. Piperazine ferulate attenuates gentamicin-induced acute kidney injury via the NF-κB/NLRP3 pathway[J]. Phytomedicine, 2022, 99: 154021.
|
| [37] |
Sun J, Guo S, Niu F, et al. Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway[J]. Mol Med Rep, 2020, 22(6): 5436-5443.
|
| [38] |
Su B, Ye H, You X, et al. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome[J]. Life Sci, 2018, 208: 26-32.
|
| [39] |
Jhou JP, Chen SJ, Huang HY, et al. Upregulation of FcγRIIB by resveratrol via NF-κB activation reduces B-cell numbers and ameliorates lupus[J]. Exp Mol Med, 2017, 49(9): e381.
|
| [40] |
He LY, Niu SQ, Yang CX, et al. Cordyceps proteins alleviate lupus nephritis through modulation of the STAT3/mTOR/NF-кB signaling pathway[J]. J Ethnopharmacol, 2023, 309: 116284.
|